BACKGROUND Intracranial bypass to treat ruptured aneurysms has been well described in the literature but is largely deferred in patients with higher Hunt & Hess (H&H) grades due to complexity… Click to show full abstract
BACKGROUND Intracranial bypass to treat ruptured aneurysms has been well described in the literature but is largely deferred in patients with higher Hunt & Hess (H&H) grades due to complexity and length of surgery, risk of inducing vasospasm, and poor prognosis. However, there is a paucity of data and no direct comparison to more traditional open surgical techniques. This study investigated outcomes in patients with H&H grade 3-5 aneurysmal subarachnoid hemorrhage (aSAH) unfavorable for standalone endovascular treatment managed with bypass compared with direct surgical clipping. METHODS A prospective database of patients treated for aSAH with H&H grade 3-5 between 2013-2018 was retrospectively analyzed. Complications and functional status at discharge and latest follow-up were compared between patients that underwent bypass surgery versus direct clipping. RESULTS Twenty-three patients underwent revascularization and 60 underwent clipping alone. There were no significant differences in all-cause 30-day mortality (15 versus 16%; p=0.97) or Glasgow Outcome Scale and modified Rankin Scale at discharge or median eight-month follow-up (p>0.67). There was a higher overall stroke rate with revascularization (p=0.004), specifically endovascular treatment-related stroke (p=0.049), with no difference in surgical (p=0.47) or vasospasm-related stroke (p=0.53). There were no differences in overall complications, medical complications, seizures, re-ruptures, hydrocephalus, or perioperative death (p>0.05). CONCLUSIONS Bypass is a viable option for patients presenting with higher H&H grade aSAH deemed unfavorable for standalone endovascular therapy. Despite obvious differences in aneurysm complexity and a higher risk of stroke, functional outcomes with revascularization can be comparable to clipping in this high-risk patient cohort.
               
Click one of the above tabs to view related content.